Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Prevention & Risk Reduction: The potential harms of acetaminophen | Recurrent stroke & marijuana
Friday, February 25, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Prevention & Risk Reduction

4 new medications and technologies that could transform cardiology in 2022

The FDA has already approved one of the medications, with a decision on another expected by the end of April. 

READ MORE >
The LDL-lowering medication inclisiran (Leqvio) was recently cleared by the FDA. It used only two doses per year. It was included it the Cleveland Clinic annual list of the top 10 medical innovations expected to make a big impact on patient care in 2022.
Share on Twitter Share on Facebook Share on Linkedin

4 new medications and technologies that could transform cardiology in 2022

Share on Twitter Share on Facebook Share on Linkedin
The LDL-lowering medication inclisiran (Leqvio) was recently cleared by the FDA. It used only two doses per year. It was included it the Cleveland Clinic annual list of the top 10 medical innovations expected to make a big impact on patient care in 2022.
The FDA has already approved one of the medications, with a decision on another expected by the end of April. 
READ MORE >

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.

READ MORE >
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Share on Twitter Share on Facebook Share on Linkedin
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.
READ MORE >

Dr. Jeremiah Stamler, a pioneer in heart research and ‘the father of preventive cardiology,’ dies

“It is no exaggeration to say that few people in history have had as great an impact on human health,” one specialist said. 

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Dr. Jeremiah Stamler, a pioneer in heart research and ‘the father of preventive cardiology,’ dies

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
“It is no exaggeration to say that few people in history have had as great an impact on human health,” one specialist said. 
READ MORE >

Eating vegetables does little to prevent cardiovascular disease

Don't give up on eating vegetables quite yet—but a new analysis in Frontiers in Nutrition does suggest they can't protect you from CVD all on their own. 

READ MORE >
Fruits vegetableshave been seen as a key component to heart health diets.
Share on Twitter Share on Facebook Share on Linkedin

Eating vegetables does little to prevent cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Fruits vegetableshave been seen as a key component to heart health diets.
Don't give up on eating vegetables quite yet—but a new analysis in Frontiers in Nutrition does suggest they can't protect you from CVD all on their own. 
READ MORE >

Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva

Trimetazidine, typically prescribed for treating angina, is associated with increasing blood flow and improving endurance.

READ MORE >
pills-medicine-rx.jpg
Share on Twitter Share on Facebook Share on Linkedin

Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva

Share on Twitter Share on Facebook Share on Linkedin
pills-medicine-rx.jpg
Trimetazidine, typically prescribed for treating angina, is associated with increasing blood flow and improving endurance.
READ MORE >

Unreliable? 76% of world’s blood pressure monitors have not been validated

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 

READ MORE >
questions.jpg
Share on Twitter Share on Facebook Share on Linkedin

Unreliable? 76% of world’s blood pressure monitors have not been validated

Share on Twitter Share on Facebook Share on Linkedin
questions.jpg
Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 
READ MORE >

Risk of recurrent stroke 48% higher among young marijuana users

Marijuana use can be especially harmful to young adults with a history of stroke or TIA, researchers explained. 

READ MORE >
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Share on Twitter Share on Facebook Share on Linkedin

Risk of recurrent stroke 48% higher among young marijuana users

Share on Twitter Share on Facebook Share on Linkedin
The new analysis, based on data from 1.6 million patients, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. Medical marijuana
Marijuana use can be especially harmful to young adults with a history of stroke or TIA, researchers explained. 
READ MORE >

Chinese herbal formula treats mild hypertension as well as prescription drug

Songling Xuemaikang capsules compare favorably with losartan, potentially providing specialists with a new treatment option. 

READ MORE >
Blood pressure
Share on Twitter Share on Facebook Share on Linkedin

Chinese herbal formula treats mild hypertension as well as prescription drug

Share on Twitter Share on Facebook Share on Linkedin
Blood pressure
Songling Xuemaikang capsules compare favorably with losartan, potentially providing specialists with a new treatment option. 
READ MORE >

'This is very exciting': New data on the link between diabetes and high blood pressure

An international research team thinks they've uncovered why so many hypertension patients also have diabetes. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

'This is very exciting': New data on the link between diabetes and high blood pressure

Share on Twitter Share on Facebook Share on Linkedin
An international research team thinks they've uncovered why so many hypertension patients also have diabetes. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme